Quanome Technologies, Inc
lakeside-holding.comWhat Do They Do?
Sells infusion products, foods for special medical purposes and specialty pharmaceuticals to hospitals, pharmaceutical distributors and other healthcare providers. It is also evaluating quantum-related technologies and building AI compute capacity and managed inference services for customers.
10-K for FY2026, filed Sep 25, 2026Our revenue from continuing pharmaceutical operations was primarily derived from selling infusion products, foods for special medical…View ↗
The Company is evaluating opportunities to reposition its business from traditional pharmaceutical distribution services toward…View ↗
Beginning in September 2026, the Company, through its indirectly wholly owned subsidiary, XDT Infrastructure I, LLC, a Delaware limited…View ↗
As of the date of this annual report, the Company has entered into an agreement to purchase 32 servers designed for high-performance…View ↗
How Do They Make Money?
It buys pharmaceutical and medical products from manufacturers and sells them to hospitals, distributors and other healthcare providers; sales count when customers accept delivery, and main customers have 0-90 days to pay.
10-K for FY2026, filed Sep 25, 2026Subsequent to the disposal of ABL Chicago, substantially all of our business is operated through Hupan Pharmaceutical. Our current…View ↗
The current payment term provided by us to our main customers is between 0-90 days; while the payment term from the supplier is 60 days.…View ↗
The Company generates revenue from the distribution of pharmaceutical and medical products. The Company orders products from the…View ↗
$5.9M
-
10-K for FY2026, filed Sep 25, 2026
$5.9M ↗
Who Are Their Customers?
Hospitals, pharmaceutical distributors and other healthcare providers buy its pharmaceutical products; sales are handled primarily through agents, while a substantial percentage of revenue comes from direct sales.
10-K for FY2026, filed Sep 25, 2026Subsequent to the disposal of ABL Chicago, substantially all of our business is operated through Hupan Pharmaceutical. Our current…View ↗
We conduct sales primarily through agents who assist with customer development, order coordination and ongoing customer relationships. Our…View ↗
The Company’s one reportable segment serves its customers primarily by providing pharmaceutical products in China. The Company generates a…View ↗
10-K for FY2026, filed Sep 25, 2026
For the year ended June 30, 2026, four third-party customers individually accounted for 22.0%, 16.4%, 12.6% and 12.6%, respectively, of the…View ↗
Do Revenues Turn Into Profits?
No. It lost $9.5M in FY2026.
Loading...
